Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
19/08/2026 22:20
BRIEF-Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting Aug 19 (Reuters) - Silo Pharma Inc SILO.O:
SILO PHARMA - ENTERS ASSET PURCHASE AGREEMENT WITH PARKVIEW CONSULTING ON AUGUST 18, 2026 - SEC FILING
SILO PHARMA - ISSUES 165,000 SHARES AS CONSIDERATION FOR ASSET PURCHASE - SEC FILING
Source text: [ID:n0001213900-26-091783]
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement